Perioperative Diabetes Management

  • Nason P. Hamlin


Optimal glycemic control in the perioperative period decreases the infection rate and other complications [1–6]. The goal is to prevent hyperglycemia, not just to react to it. The traditional practice of writing only for a “sliding scale” as well as the term “sliding scale” should be abandoned [7]. Good glycemic control requires you to be proactive, not just reactive. Think in terms of basal, prandial (mealtime), and correction insulin therapy. Although some concerns have been raised about “intensive” insulin therapy because of the risk of hypoglycemia, this does not negate the benefit of optimal glucose control, the definition of which includes minimizing hypoglycemia [8–12].


Insulin Infusion Basal Insulin Insulin Requirement Regular Insulin Good Glycemic Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Frisch A, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33:1783–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr. 1998;22(2):77–81.CrossRefGoogle Scholar
  3. 3.
    Dellinger EP. Preventing surgical-site infections: the importance of timing and glucose control. Infect Control Hosp Epidemiol. 2001;22:604–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Inzucchi SE. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(18):1903–11.PubMedCrossRefGoogle Scholar
  5. 5.
    Ramos M, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg. 2008;248:585–91.PubMedGoogle Scholar
  6. 6.
    Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient ­glycemic control. Endocr Pract. 2009;15(4):1–17.CrossRefGoogle Scholar
  7. 7.
    Hirsch IB. Sliding scale insulin-time to stop sliding. JAMA. 2009;301(2):213–4.PubMedCrossRefGoogle Scholar
  8. 8.
    The NICE-STUDY Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.CrossRefGoogle Scholar
  9. 9.
    Inzucchi SE, Siegle MD. Glucose control in the ICU—how tight is too tight? N Engl J Med. 2009;360(13):1346–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including the NICE-SUGAR study data. CMAJ. 2009;180(8):821–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Joint Statement from ADA and AACE on the NICE-SUGAR study on intensive versus ­conventional glucose control in critically ill patients. 2009 Mar 25. Accessed online at:  =  4886Google Scholar
  12. 12.
    Kasangara D, et al. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med. 2011;154:268–82.Google Scholar
  13. 13.
    Lipska KJ, et al. Use of metformin in the setting of mild to moderate renal insufficiency. Diabetes Care. 2011;34(6):1431–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, Seley JJ, Van den Berghe G, Endocrine Society. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Nason P. Hamlin
    • 1
  1. 1.Department of Medicine, Division of General Internal MedicineUniversity of Washington Medical CenterSeattleUSA

Personalised recommendations